NEW YORK (GenomeWeb) – Bruker reported after the close of the market on Thursday that its second quarter revenues were up 7 percent year over year, driven by growth in its scientific instruments business.

For the three months ended June 30, Billerica, Massachusetts-based Bruker reported revenues of $443.7 million, compared to $414.9 million in Q2 2017.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.